Author: IQ TIMES MEDIA

Tesla has pushed back the reveal of its long-delayed next-generation Roadster — again. But Elon Musk says it could arrive as soon as late next month.On Tuesday, the Tesla CEO said on X that the company will “hopefully” unveil the electric sports car next month, “probably in late April.”That timeline is already slipping from Musk’s recent guidance. In an October interview with podcaster Joe Rogan, Musk said the car would be released “hopefully before the end of the year.” Then, in November, during Tesla’s annual shareholder meeting, he said that the company was “tentatively aiming” to have the demo event…

Kalshi’s legal battle with states is heating up.Arizona Attorney General Kris Mayes on Tuesday filed criminal charges against the online gambling company — a first for the company in its expanding battle with states. Kalshi lets people bet on real-world events, from who will win a pro sports game to the weather.Mayes’s 20-count filing against the prediction market platform includes 16 charges of operating an unlicensed gambling business and four charges of election wagering. All of the charges are misdemeanors and could carry potential fines.”Kalshi may brand itself as a ‘prediction market,’ but what it’s actually doing is running an…

This as-told-to essay is based on conversations with Amit Jain and Raghav Saraf, cofounders of Bengaluru-based agentic AI startup Zamp. It has been edited for length and clarity. Loading audio narration… Raghav Saraf: I joined Zamp four days after my last high school exam ended in 2022. I met Amit at a blockchain hackathon I had participated in, where I built a payment gateway. My product was really similar to what Amit was trying to build at Zamp, and the hackathon organizer introduced us.Amit Jain: Before I founded Zamp, I was a managing director at Sequoia India and Southeast Asia…

Not long ago, a restaurant’s edge was its secret sauce. Now, it might be its source code. Loading audio narration… From McDonald’s “Experience of the Future” initiative, which expanded the rollout of in-restaurant kiosks and app-based ordering, to Chipotle’s Autocado, which automatically cuts and peels avocados, the trend is accelerating across the industry. Even Starbucks, long known for its human-centric “third place” positioning, recently introduced a generative AI tool for baristas called Green Dot to provide real-time support inside stores.Whether they’re selling pretzels, burgers, or lattes, major chains are building internal AI copilots, rearchitecting their data systems, and operating their…

By Danilo Masoni MILAN (Reuters) -Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares remain in the doldrums, highlighting uncertainty over drug pricing policies since Donald Trump returned to the White House. Pharma companies’ earnings outlook is being obscured by concerns over revived “most-favored-nation” drug pricing rules in the lucrative U.S. market and potential 200% tariffs on pharma imports into the U.S. Money flooded into drugmakers’ shares during the COVID-19 pandemic but more recently there has been an exodus as investors shifted into Big Tech, leaving the…

(Reuters) -Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported on Wednesday, citing people familiar with the matter. Shares of Avidity rose 23% to $47.1. It has a market value of $4.6 billion, according to LSEG data. Novartis has been evaluating a bid for Avidity and expressed interest in an acquisition in recent weeks, the report said, in a move aimed at boosting the drugmaker’s pipeline of medicines targeting rare genetic disorders. The discussions were at an early stage, the report said, adding that the sources had cautioned that another suitor…

WASHINGTON (AP) — Shares of drugmaker Sarepta Therapeutics continued to fall Tuesday after the company said it would comply with a Food and Drug Administration request to pause shipments of its gene therapy following several patient deaths. The decision, announced late Monday, comes just days after the company rebuffed FDA regulators in an extremely unusual decision that alarmed investors and analysts. Sarepta CEO Doug Ingram said the company seeks a “productive and positive” relationship with FDA and that “maintaining that productive working relationship required this temporary suspension.” The Cambridge, Massachusetts-based company said it would “ temporarily pause all shipments” of…

WASHINGTON (AP) — Shares of beleaguered drugmaker Sarepta Therapeutics jumped in afterhours trading Monday after the company said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators. The Food and Drug Administration said it recommended lifting the hold for young patients with Duchenne’s muscular dystrophy who are still able to walk. Regulators had requested the pause after the deaths of two older teenagers who were taking the therapy. The FDA also said in a statement it determined that a recently reported death of an 8-year-old boy was unrelated to the therapy. Company…

CVS Health topped Wall Street expectations for the second quarter and hiked its full-year forecast again, as the health care giant continued to rally under new management from a forgettable 2024. The company said Thursday it now expects adjusted 2025 earnings to range between $6.30 and $6.40 this year after hiking the forecast to a range of up to $6.20 per share in May. Analysts have forecast annual forecast earnings of $6.12 per share, according to the data firm FactSet. In the second quarter, CVS Health reported adjusted earnings of $1.81 per share as revenue grew 8% to $98.9 billion.…

Melissa Shaw.Courtesy of Melissa Shaw Melissa Shaw became her mother’s primary caregiver after a sudden terminal cancer diagnosis. Shaw, a financial advisor, learned crucial lessons about end-of-life planning and caregiving. Her biggest lessons include the importance of Medigap, healthcare proxies, and life insurance. This as-told-to essay is based on a conversation with Melissa Shaw, a 46-year-old financial advisor in Palo Alto, California. It has been edited for length and clarity. I’ve been a financial advisor since 2011 and have worked at Teachers Insurance and Annuity Association of America, or TIAA, as a wealth management advisor for over seven years. I…